Related Experiment Video
Updated: Jul 5, 2026

Method to Visualize and Analyze Membrane Interacting Proteins by Transmission Electron Microscopy
Published on: March 5, 2017
Regulate PD-L1's membrane orientation thermodynamics with hydrophobic nanoparticles
Xiaoqian Lin1,2,3, Xubo Lin1
1Beijing Advanced Innovation Center for Biomedical Engineering, Key Laboratory of Ministry of Education for Biomechanics and Mechanobiology, School of Engineering Medicine & School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China. linxbseu@buaa.edu.cn.
Abstract:
Tumor cells can escape from immune killing by binding their programmed death ligand-1 (PD-L1) to the programmed cell death protein 1 (PD-1) of T cells. These immune checkpoint proteins (PD-L1/PD-1) have become very important drug targets, since blocking PD-L1 or PD-1 can recover the killing capability of T cells against tumor cells. Instead of targeting the binding interface between PD-L1 and PD-1, we explored the possibility of regulating the membrane orientation thermodynamics of PD-L1 with ligand-modified ultra-small hydrophobic nanoparticles (NPs) using μs-scale coarse-grained molecular dynamics (MD) simulations in this work. Our MD results indicate that embedded hydrophobic NPs can significantly change the membrane orientation thermodynamics of the extracellular domain of PD-L1, enhancing the probability in the "stand up" state for better binding to PD-1. Meanwhile, embedded hydrophobic NPs promote the tilt of the transmembrane domain of PD-L1. Besides, effects on both extracellular and transmembrane domains are determined by the ligand length and NP concentration. Our study may provide an alternative strategy to achieve PD-L1-related immunotherapy with nanomedicine.
Insights
Hydrophobic nanoparticles alter the membrane orientation of PD-L1, enhancing T cell engagement for cancer immunotherapy. This nanomedicine approach offers a novel strategy beyond traditional PD-L1/PD-1 blocking therapies.
Area of Science:
- Biophysics
- Immunology
- Nanomedicine
Background:
- Tumor cells evade immune detection via the PD-L1/PD-1 pathway.
- Targeting PD-L1 or PD-1 is a key strategy in cancer immunotherapy.
- Current therapies focus on blocking the PD-L1/PD-1 binding interface.
Purpose of the Study:
- To investigate nanoparticle-mediated regulation of PD-L1 membrane orientation.
- To explore an alternative nanomedicine strategy for PD-L1-related immunotherapy.
Main Methods:
- Utilized microsecond-scale coarse-grained molecular dynamics (MD) simulations.
- Simulated ligand-modified ultra-small hydrophobic nanoparticles (NPs).
- Analyzed the effect of NPs on PD-L1's extracellular and transmembrane domains.
Main Results:
- Embedded hydrophobic NPs enhance the "stand up" state probability of PD-L1's extracellular domain.
- Hydrophobic NPs promote tilting of PD-L1's transmembrane domain.
- Ligand length and NP concentration influence these effects.
Conclusions:
- Nanoparticle interaction with PD-L1 offers a novel immunotherapy strategy.
- This approach modulates PD-L1 thermodynamics for improved T cell interaction.
- Findings suggest a new nanomedicine avenue for cancer treatment.

